SCHEMBL4902995

SCHEMBL4902995

CCc1ccc(-c2ccc(N(CC)S(=O)(=O)c3ccc(C)c(C(=O)OC)c3)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR2 O43614 1/20 0.47
ALDH1A1 P00352 5/20 0.47
TSHR P16473 2/20 0.47
LMNA P02545 4/20 0.46
ESR1 P03372 2/20 0.46
MAPT P10636 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
TP53 P04637 2/20 0.43
RORC P51449 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
HPGD P15428 1/20 0.43
ALOX15 P16050 1/20 0.43
HSD17B10 Q99714 1/20 0.43
ATM Q13315 2/20 0.42
PKM P14618 2/20 0.42
GAA P10253 1/20 0.42
PTGES O14684 1/20 0.40
ALOX5 P09917 1/20 0.40
KDM4E B2RXH2 1/20 0.40
TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4905482 0.92 NPSR1 (0.51) HCRTR2ALDH1A1TSHRLMNAESR1
SCHEMBL4906761 0.92 ALDH1A1 (0.48) ALDH1A1TSHRLMNAESR1MAPT
SCHEMBL4899320 0.90 ALDH1A1 (0.52) ALDH1A1TSHRLMNAESR1MAPT
SCHEMBL4898279 0.90 MAPT (0.51) ALDH1A1TSHRLMNAESR1MAPT
SCHEMBL4904034 0.90 LMNA (0.50) HCRTR2ALDH1A1TSHRLMNAESR1
SCHEMBL4904116 0.89 LMNA (0.56) HCRTR2ALDH1A1LMNAESR1MAPT
SCHEMBL4900672 0.88 HDAC8 (0.51) HCRTR2ALDH1A1TSHRLMNAESR1
SCHEMBL4908535 0.88 LMNA (0.54) ALDH1A1TSHRLMNAESR1MAPT
SCHEMBL4909029 0.88 ALDH1A1 (0.47) HCRTR2ALDH1A1TSHRLMNAESR1
SCHEMBL4905146 0.88 ALDH1A1 (0.50) HCRTR2ALDH1A1TSHRLMNAESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD HCRTR2 3933/4885ALDH1A1 2956/4885TSHR 400/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD HCRTR2 3933/4885ALDH1A1 2956/4885TSHR 400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.